Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline in Resectable Pancreatic Cancer
NCT02775695Phase 2Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Apr 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline in pancreatic adenocarcinoma (PDAC), sponsored by Medical College of Wisconsin. Started Apr 2017; status: completed.
02
Drugs
doxycycline
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02775695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02775695.